Dishman Carbogen

43
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE385W01011
  • NSEID: DCAL
  • BSEID: 540701
INR
224.00
-4.6 (-2.01%)
BSENSE

Dec 05

BSE+NSE Vol: 1.65 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Dishman Carbogen Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
19.00
-122.00
-54.00
-4.00
-65.00
197.00
Adjustment
466.00
376.00
392.00
325.00
312.00
330.00
Changes In working Capital
-80.00
143.00
-37.00
90.00
316.00
132.00
Cash Flow after changes in Working Capital
405.00
398.00
300.00
411.00
563.00
659.00
Cash Flow from Operating Activities
375.00
379.00
265.00
354.00
512.00
585.00
Cash Flow from Investing Activities
-196.00
-224.00
-494.00
-618.00
-380.00
-441.00
Cash Flow from Financing Activities
-102.00
-22.00
249.00
130.00
-11.00
-97.00
Net Cash Inflow / Outflow
76.00
132.00
21.00
-133.00
121.00
45.00
Opening Cash & Cash Equivalents
264.00
131.00
110.00
243.00
121.00
76.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
341.00
264.00
131.00
110.00
243.00
121.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dishman Carbogen
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
19.31
211.77
-192.00
-90.88%
Adjustment
466.83
84.34
382.00
453.51%
Changes In working Capital
-80.59
3.59
-83.00
-2344.85%
Cash Flow after changes in Working Capital
405.55
299.7
106.00
35.32%
Cash Flow from Operating Activities
375.23
244.58
131.00
53.42%
Cash Flow from Investing Activities
-196.16
-164.63
-32.00
-19.15%
Cash Flow from Financing Activities
-102.09
-82.12
-20.00
-24.32%
Net Cash Inflow / Outflow
76.98
-2.17
78.00
3647.47%
Opening Cash & Cash Equivalents
264.09
6.74
258.00
3818.25%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
341.07
4.58
337.00
7346.94%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -1.11% vs 42.66% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
375.23
379.43
-1.11%